Sodium‐glucose cotransporter 2 inhibitor luseogliflozin improves glycaemic control, assessed by continuous glucose monitoring, even on a low‐carbohydrate diet

di Nishimura, R., Omiya, H., Sugio, K., Ubukata, M., Sakai, S., Samukawa, Y.
Pubblicato in Diabetes Obes Metab (2016)

Carcinogenicity in mice and rats of heterocyclic amines in cooked foods.

di Ohgaki, H, Hasegawa, H, Kato, T, Suenaga, M, Ubukata, M, Sato, S, Takayama, S, Sugimura, T
Pubblicazione 1986

Effects of luseogliflozin, a sodium–glucose co‐transporter 2 inhibitor, on 24‐h glucose variability assessed by continuous glucose monitoring in Japanese patients with type 2 diabe...

di Nishimura, R., Osonoi, T., Kanada, S., Jinnouchi, H., Sugio, K., Omiya, H., Ubukata, M., Sakai, S., Samukawa, Y.
Pubblicato in Diabetes Obes Metab (2015)